Mr Mitchell Nussbaum > Loeb & Loeb LLP > New York, United States > Lawyer Profile

With a strong following of start-ups, emerging growth companies, large corporations, private equity and venture capital funds, Loeb & Loeb LLP has established a good reputation in the middle-market M&A space in the US. The firm’s deep roots in the media and entertainment sectors, and longstanding experience in the tech and digital content space make it a go-to destination for business transactions in these spheres. The practice’s cross-border capabilities are also noteworthy, as are its credentials in distressed deals and SPAC acquisitions. Mitchell Nussbaum in New York, who regularly advises public companies on their SEC and NYSE or Nasdaq listing compliance, co-chairs the capital markets and corporate department with Los Angeles-based Arash Khalili, an active dealmaker in the TMT, sports, and healthcare sectors. Based in the New York office, assistant deputy chairs Lloyd Rothenberg and Ronelle Porter handle a mix of corporate, M&A and capital markets work. Giovanni Caruso is another key practitioner in New York; he is a member ‘one of the very best teams in SPAC-related work’.

Loeb & Loeb LLP‘s chiefly New York based practice handles the full scope of life sciences mandates, including adverse event reporting and response, patent enforcement, and the approval of biosimilars and biologics products. Fran Stoller advises both public and private biotech, pharmaceutical, and technology companies on corporate and financing transactions, in addition to research and development collaborations. Mark Waddell handles the patent litigation side of the practice, representing drug companies in biosimilars and Hatch-Waxman related matters concerning exclusivity protection. Mitchell Nussbaum maintains a corporate and capital markets focused practice, routinely advising on private placements, IPOs, and proxy contests.